These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9389293)

  • 21. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intranasal capsaicin on symptoms and mediator release.
    Bascom R; Kagey-Sobotka A; Proud D
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1323-7. PubMed ID: 1762079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal mucosal endorgan hyperresponsiveness.
    Svensson C; Andersson M; Greiff L; Persson CG
    Am J Rhinol; 1998; 12(1):37-43. PubMed ID: 9513658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.
    Frieri M; Therattil J; Chavarria V; Cosachov J; Kumar NS; Wang SF; Sansone G; Etzel J; Dellevecchia D; Zitt M; Mesarina-Wicki B; Nolop KB
    Ann Allergy Asthma Immunol; 1998 Nov; 81(5):431-7. PubMed ID: 9860036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin.
    Lacroix JS; Buvelot JM; Polla BS; Lundberg JM
    Clin Exp Allergy; 1991 Sep; 21(5):595-600. PubMed ID: 1742652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
    Baraniuk JN; Silver PB; Kaliner MA; Barnes PJ
    J Appl Physiol (1985); 1992 Nov; 73(5):1867-72. PubMed ID: 1282125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R; Pagano C; Low JL; Church MK; Crimi N
    Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggravation of airway inflammation and hyper-responsiveness following nasal challenge with Dermatophagoides pteronyssinus in perennial allergic rhinitis without symptoms of asthma.
    Wang W; Xian M; Xie Y; Zheng J; Li J
    Allergy; 2016 Mar; 71(3):378-86. PubMed ID: 26595454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsaicin desensitization of the nasal mucosa reduces symptoms upon allergen challenge in patients with allergic rhinitis.
    Stjärne P; Rinder J; Hedén-Blomquist E; Cardell LO; Lundberg J; Zetterström O; Anggård A
    Acta Otolaryngol; 1998 Mar; 118(2):235-9. PubMed ID: 9583792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural hyperresponsiveness and nerve growth factor in allergic rhinitis.
    Sanico AM; Koliatsos VE; Stanisz AM; Bienenstock J; Togias A
    Int Arch Allergy Immunol; 1999; 118(2-4):154-8. PubMed ID: 10224365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of leukotriene D
    Zhu Z; Xie Y; Guan W; Gao Y; Xia S; Huang R; Zhong N; Zheng J
    Clin Respir J; 2018 Feb; 12(2):587-594. PubMed ID: 27696764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
    Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
    Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intranasal histamine on the cough reflex in subjects with allergic rhinitis.
    Plevkova J; Brozmanova M; Pecova R; Tatar M
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():185-95. PubMed ID: 16204792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal lavage as a tool in assessing acute inflammation in response to inhaled pollutants.
    Koren HS; Hatch GE; Graham DE
    Toxicology; 1990; 60(1-2):15-25. PubMed ID: 2315937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.